118 related articles for article (PubMed ID: 38861030)
21. Heme oxygenase-1 directly binds STAT3 to control the generation of pathogenic Th17 cells during neutrophilic airway inflammation.
Lin XL; Lv JJ; Lv J; Di CX; Zhang YJ; Zhou T; Liu JL; Xia ZW
Allergy; 2017 Dec; 72(12):1972-1987. PubMed ID: 28580587
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional modulation of the T helper 17/interleukin 17 axis ameliorates renal ischemia-reperfusion injury.
Lee JW; Bae E; Kwon SH; Yu MY; Cha RH; Lee H; Kim DK; Lee JP; Ye SK; Yoo JY; Park DJ; Kim YS; Yang SH
Nephrol Dial Transplant; 2019 Sep; 34(9):1481-1498. PubMed ID: 30544214
[TBL] [Abstract][Full Text] [Related]
23. Worsening of imiquimod-induced psoriasiform inflammation in mice by environmental pollutant, di-(2-ethylhexyl) phthalate through dysregulation in IL-17A and Nrf2/iNOS signaling in peripheral myeloid and CD4 + T cells.
Alfardan AS; Nadeem A; Ahmad SF; Al-Harbi NO; Alqinyah M; Attia SM; Sarawi W; Alanazi AZ; Alhazzani K; Ibrahim KE
Int Immunopharmacol; 2024 Jan; 126():111293. PubMed ID: 38056199
[TBL] [Abstract][Full Text] [Related]
24. A Novel
Deng M; Li Y; Li Y; Mao X; Ke H; Liang W; Lei X; Lau YL; Mao H
Front Immunol; 2022; 13():866638. PubMed ID: 35677041
[TBL] [Abstract][Full Text] [Related]
25. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.
Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF
J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873
[TBL] [Abstract][Full Text] [Related]
26. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
Front Immunol; 2021; 12():635076. PubMed ID: 34025642
[TBL] [Abstract][Full Text] [Related]
27. STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2D
Masle-Farquhar E; Jackson KJL; Peters TJ; Al-Eryani G; Singh M; Payne KJ; Rao G; Avery DT; Apps G; Kingham J; Jara CJ; Skvortsova K; Swarbrick A; Ma CS; Suan D; Uzel G; Chua I; Leiding JW; Heiskanen K; Preece K; Kainulainen L; O'Sullivan M; Cooper MA; Seppänen MRJ; Mustjoki S; Brothers S; Vogel TP; Brink R; Tangye SG; Reed JH; Goodnow CC
Immunity; 2022 Dec; 55(12):2386-2404.e8. PubMed ID: 36446385
[TBL] [Abstract][Full Text] [Related]
28. Oncostatin M Suppresses Activation of IL-17/Th17 via SOCS3 Regulation in CD4+ T Cells.
Son HJ; Lee SH; Lee SY; Kim EK; Yang EJ; Kim JK; Seo HB; Park SH; Cho ML
J Immunol; 2017 Feb; 198(4):1484-1491. PubMed ID: 28093521
[TBL] [Abstract][Full Text] [Related]
29. A negative feedback loop mediated by STAT3 limits human Th17 responses.
Purvis HA; Anderson AE; Young DA; Isaacs JD; Hilkens CM
J Immunol; 2014 Aug; 193(3):1142-50. PubMed ID: 24973454
[TBL] [Abstract][Full Text] [Related]
30. Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
Tanaka S; Suto A; Iwamoto T; Kashiwakuma D; Kagami S; Suzuki K; Takatori H; Tamachi T; Hirose K; Onodera A; Suzuki J; Ohara O; Yamashita M; Nakayama T; Nakajima H
J Exp Med; 2014 Aug; 211(9):1857-74. PubMed ID: 25073789
[TBL] [Abstract][Full Text] [Related]
31. Cutting Edge: Systemic Autoimmunity in Murine STAT3 Gain-of-Function Syndrome Is Characterized by Effector T Cell Expansion in the Absence of Overt Regulatory T Cell Dysfunction.
Woods J; Pemberton SE; Largent AD; Chiang K; Liggitt D; Oukka M; Rawlings DJ; Jackson SW
J Immunol; 2022 Sep; 209(6):1033-1038. PubMed ID: 35995509
[TBL] [Abstract][Full Text] [Related]
32. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells.
Ryu JG; Lee J; Kim EK; Seo HB; Park JS; Lee SY; Moon YM; Yoo SH; Park YW; Park SH; Cho ML; Kim HY
Immunol Lett; 2015 Feb; 163(2):143-50. PubMed ID: 25447400
[TBL] [Abstract][Full Text] [Related]
33. Halofuginone-induced amino acid starvation regulates Stat3-dependent Th17 effector function and reduces established autoimmune inflammation.
Carlson TJ; Pellerin A; Djuretic IM; Trivigno C; Koralov SB; Rao A; Sundrud MS
J Immunol; 2014 Mar; 192(5):2167-76. PubMed ID: 24489094
[TBL] [Abstract][Full Text] [Related]
34. Psoriatic inflammation enhances allergic airway inflammation through IL-23/STAT3 signaling in a murine model.
Nadeem A; Al-Harbi NO; Ansari MA; Al-Harbi MM; El-Sherbeeny AM; Zoheir KMA; Attia SM; Hafez MM; Al-Shabanah OA; Ahmad SF
Biochem Pharmacol; 2017 Jan; 124():69-82. PubMed ID: 27984001
[TBL] [Abstract][Full Text] [Related]
35. Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice.
Kim CH; Yoo JK; Jeon SH; Lim CY; Lee JH; Koo DB; Park MY
Scand J Immunol; 2019 Mar; 89(3):e12742. PubMed ID: 30548969
[TBL] [Abstract][Full Text] [Related]
36. Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.
Itoh T; Hatano R; Komiya E; Otsuka H; Narita Y; Aune TM; Dang NH; Matsuoka S; Naito H; Tominaga M; Takamori K; Morimoto C; Ohnuma K
J Invest Dermatol; 2019 Apr; 139(4):878-889. PubMed ID: 30423328
[TBL] [Abstract][Full Text] [Related]
37. Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.
Faletti L; Ehl S; Heeg M
Biomed J; 2021 Aug; 44(4):412-421. PubMed ID: 34366294
[TBL] [Abstract][Full Text] [Related]
38. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
39. Rosmarinic acid protects mice from imiquimod induced psoriasis-like skin lesions by inhibiting the IL-23/Th17 axis via regulating Jak2/Stat3 signaling pathway.
Zhang M; Li N; Cai R; Gu J; Xie F; Wei H; Lu C; Wu D
Phytother Res; 2021 Aug; 35(8):4526-4537. PubMed ID: 34008239
[TBL] [Abstract][Full Text] [Related]
40. [Effect of fire needling on imiquimod induced psoriasis-like lesion and STAT3 pathway in mice].
Feng F; Wang Y; Zhao JX; Di TT; Meng YJ; Chen ZX; Qi C; Hu XQ; Wang YZ; Li P
Zhongguo Zhen Jiu; 2022 May; 42(5):541-8. PubMed ID: 35543945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
